I think that it's important to remember that there is not a one-size-fits-all answer to the question of "which treatment is best for me?" (I know that you aren't suggesting otherwise, but I'm feeling inspired to make additional comments.
) The biology of each case can be so different, each patient's personal situation can be so different (age, health, personality, etc)...there simply will never be a single solution for treating PC.
Some (not all) cases have a real choice in primary treatments, and in those cases it's both a blessing and a curseāa blessing to actually have options with similar outcomes to choose from, but a curse to have to choose one.
Looking a little further down the road than this chart projects (2012), my crystal ball has a continued increase in use of targetted focal therapies (TFT) and Cyberknife...again, these are not options for all cases, but as these solutions continue to mature from both a process and equipment perspective, I think these will increasing be seen as excellent alternatives. Over time, we will continue to be less freaked-out by the "big-C" word with prostate cancer and for the guys who continue to be increasingly accurately defined as low risk, we will treat PC more as a chronic disease.
If you'd like me to read your palm, I can do that too...
----------------------------------------------------------------------
Added later: It was interesting that one comment accompanying this chart was that the increase in IMRT/IGRT was projected to be largely driven by economic factors. More doctors are installing the (very expensive) equipment right in their offices, so that they can steer you conveniently right into the treatment room...one-stop shopping can be popular.
Post Edited (Casey59) : 2/4/2011 9:51:14 AM (GMT-7)